Kanya Rajangam's Net Worth
$718 Thousand
Who is Kanya Rajangam?
Kanya Rajangam does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Senti Biosciences, Inc., Nkarta, Inc., and Turnstone Biologics Corp..
SEC CIK
Kanya Rajangam's CIK is 0001816676
Past Insider Trading and Trends
2022 was Kanya Rajangam's most active year for acquiring shares with 3 total transactions. Kanya Rajangam's most active month to acquire stocks was the month of December. 2021 was Kanya Rajangam's most active year for disposing of shares, totalling 2 transactions. Kanya Rajangam's most active month to dispose stocks was the month of July. 2021 saw Kanya Rajangam paying a total of $4,100.00 for 62,500 shares, this is the most they've acquired in one year. In 2021 Kanya Rajangam cashed out on 20,000 shares for a total of $372,800.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Senti Biosciences, Inc. (SNTI) Snapshot price: $2.8
Chief Medical & Devt. OfficerKanya Rajangam owns 101,000 units of Common Stock which is worth $282,800.00.acquired a total of 101,000 shares in Senti Biosciences, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 101K |
—
|
—
| 101K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nkarta, Inc. (NKTX) Snapshot price: $5.2
Chief Medical OfficerKanya Rajangam owns 12,800 units of Common Stock which is worth $66,560.00. In the year 2020 Kanya Rajangam filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.8K |
—
|
—
| 12.8K |
Jan 14
| |||
Form 4
|
—
|
0
|
$18.85 | -$368,700.00 |
0
|
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Turnstone Biologics Corp. (TSBX) Snapshot price: $0.5884
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |